Sign In
Buy CLSD
$0.410
+0 (+0%)
At Close: Mar 13, 2026
Clearside Biomedical Expands XIPERE™ License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN Countries
07:05am, Thursday, 09'th Sep 2021
– Increasing Global Awareness of Innovative Suprachoroidal Injection Platform – – Increasing Global Awareness of Innovative Suprachoroidal Injection Platform –
Clearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina Forum
04:05pm, Monday, 23'rd Aug 2021
ALPHARETTA, Ga., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vi
SHANGHAI, Aug. 15, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today the entering of an amendment to the exclusive license
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q2 2021 Results - Earnings Call Transcript
10:46pm, Tuesday, 10'th Aug 2021
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q2 2021 Results - Earnings Call Transcript
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Tops Revenue Estimates
07:19pm, Tuesday, 10'th Aug 2021
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 8.33% and 5.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock
Clearside Biomedical: Q2 Earnings Insights
05:11pm, Tuesday, 10'th Aug 2021
Shares of Clearside Biomedical (NASDAQ:CLSD) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 15.38% over the past year to ($0.11),
Clearside's Value Proposition Is Far From Clear
11:33am, Saturday, 07'th Aug 2021
Clearside is developing treatments for diseases of the suprachoroidal space of the eye. However, even its latest stage asset has very little monetary value.
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021
07:05am, Wednesday, 04'th Aug 2021
ALPHARETTA, Ga., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vi
Will Clearside Biomedical, Inc. (CLSD) Report Negative Earnings Next Week? What You Should Know
04:47pm, Tuesday, 03'rd Aug 2021
Clearside Biomedical, Inc. (CLSD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Which Penny Stocks Are Investors Buying Right Now? Check These 7 Out
03:15pm, Monday, 05'th Jul 2021
Looking for the best penny stocks to watch right now? Check these 7 out The post Which Penny Stocks Are Investors Buying Right Now?
Why Clearside Biomedical Stock Surged Today
03:38pm, Thursday, 17'th Jun 2021
Analysts are excited about the biotech's investigational treatment for a common eye disorder.
Why Opthea Stock Skyrocketed Today
04:06pm, Wednesday, 16'th Jun 2021
The big gain appears to be a sympathy move related to positive news for another drugmaker.
4 Penny Stocks Reddit Traders Are Buying Right Now
11:46am, Wednesday, 16'th Jun 2021
Looking for penny stocks to buy on Reddit? Check these 4 out for your watchlist The post 4 Penny Stocks Reddit Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Infor
Do Options Traders Know Something About Clearside Biomedical (CLSD) Stock We Don't?
09:46am, Wednesday, 16'th Jun 2021
Investors need to pay close attention to Clearside Biomedical (CLSD) stock based on the movements in the options market lately.
CLSD Stock Price Increased 37.75%: Why It Happened
07:40am, Wednesday, 16'th Jun 2021
The stock price of Clearside Biomedical, Inc. (Nasdaq: CLSD) increased 37.75% yesterday. This is why it happened.
